Issue: November 2022
Fact checked byRichard Smith

Read more

November 23, 2022
1 min read
Save

APOLLO-B

Issue: November 2022
Fact checked byRichard Smith
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Evaluating efficacy and safety of patisiran (Onpattro, Alnylam) in adults with transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.